Current Perspectives in Mesenchymal Stem Cell Therapies for Osteoarthritis

Osteoarthritis (OA) is a degenerative joint disease most commonly occurring in the ageing population. It is a slow progressive condition resulting in the destruction of hyaline cartilage followed by pain and reduced activity. Conventional treatments have little effects on the progression of the condition often leaving surgery as the last option. In the last 10 years tissue engineering utilising mesenchymal …

New Publication Elaborates on TB4’s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders

ROCKVILLE, Md., Aug. 12, 2015 /PRNewswire RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced a new peer-reviewed publication describing Thymosin beta 4’s (TB4) effects on dry eye syndrome and its potential value for the treatment of other ophthalmic disorders. The authors of the paper explained …